Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study Benchmarking FREEDOM Substudy to Evaluate the Effects of Amorphous Calcium Carbonate in Postmenopausal Women

NCT06728462 is registered in ClinicalTrials.gov with Universal Integrated Corp. as lead sponsor.

NCT NCT06728462
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06728462 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study Benchmarking FREEDOM Substudy to Evaluate the Effects of Amorphous Calcium Carbonate in Postmenopausal Women
Lead sponsor
Universal Integrated Corp.
Phase
Not applicable
Overall status
Recruiting
Start date
March 4, 2025
Completion date
March 1, 2027
Enrollment
205 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bone mineral density, bone turnover marker, calcium, denosumab, osteoporosis